CoChat

Use of the Desmopressin Test in the Differential Diagnosis of Pseudo-Cushing State from Cushing’s Disease

Tirabassi, Giacomo, Faloia, Emanuela, Papa, Roberta, Furlani, Giorgio, Boscaro, Marco, Arnaldi, Giorgio · 2010 · The Journal of Clinical Endocrinology & Metabolism
Cited by 90

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

CONTEXT: The desmopressin (DDAVP) test has been proposed to discriminate Cushing's disease (CD) from pseudo-Cushing states (PC); however, current information on its value is scarce and contradictory. OBJECTIVE: The aim of the study was to assess the ability of the DDAVP test in distinguishing between these conditions, with emphasis on subjects with mild hypercortisolism. DESIGN AND SETTING: We conducted a retrospective/prospective study at the Division of Endocrinology, Polytechnic University of Marche, Ancona, Italy. PATIENTS: The study included 52 subjects with CD, 28 with PC, and 31 control subjects (CT). INTERVENTION(S): We performed the DDAVP test and standard diagnostic procedures for the diagnosis of Cushing's syndrome. MAIN OUTCOME MEASURE(S): The diagnosis/exclusion of CD was measured. RESULTS: Interpretation of the DDAVP test based on percentage and absolute increment of cortisol and ACTH did not afford acceptable values of both sensitivity (SE) and specificity (SP). CD diagnosis based on simultaneous positivity for basal serum cortisol greater than 331 nmol/liter and absolute ACTH increment greater than 4 pmol/liter and its exclusion in subjects negative for one or both measures yielded an SE of 90.3% and an SP of 91.5%. The approach was also highly effective in distinguishing PC from: 1) CD with moderate values of urinary free cortisol (SE, 86.9%; SP, 92.8%); 2) CD with moderate values of serum cortisol after dexamethasone suppression (SE, 86.6%; SP, 92.8%); and 3) CD with moderate values of midnight serum cortisol (SE, 100%; SP, 92.8%). CONCLUSIONS: Interpretation of the DDAVP test through a combination of parameters allowed effective discrimination of CD from PC, even in subjects with mild hypercortisolism.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2009-1146

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 30

  1. Boscaro, 2009, Approach to the patient with possible Cushing’s syndrome, J Clin Endocrinol Metab, 94, 3121, 10.1210/jc.2009-0612 · DOI · Paper page
  2. Moro, 2000, The desmopressin test in the differential diagnosis between Cushing’s disease and pseudo-Cushing states, J Clin Endocrinol Metab, 85, 3569
  3. Malerbi, 1996, Cortisol and adrenocorticotropin response to desmopressin in women with Cushing’s disease compared with depressive illness, J Clin Endocrinol Metab, 81, 2233
  4. Arnaldi, 1998, Vasopressin receptors modulate the pharmacological phenotypes of Cushing’s syndrome, Endocr Res, 24, 807, 10.3109/07435809809032691 · DOI
  5. de Keyzer, 1998, Overexpression of vasopressin (V3) and corticotrophin-releasing hormone receptor genes in corticotroph tumours, Clin Endocrinol (Oxf), 49, 475, 10.1046/j.1365-2265.1998.00560.x · DOI · Paper page
  6. Gatta, 2007, Reevaluation of the combined dexamethasone suppression-corticotropin-releasing hormone test for differentiation of mild Cushing’s disease from pseudo-Cushing’s syndrome, J Clin Endocrinol Metab, 92, 4290, 10.1210/jc.2006-2829 · DOI · Paper page
  7. Erickson, 2007, Dexamethasone-suppressed corticotropin-releasing hormone stimulation test for diagnosis of mild hypercortisolism, J Clin Endocrinol Metab, 92, 2972, 10.1210/jc.2006-2662 · DOI · Paper page
  8. American Psychiatric Association, 1994, Diagnostic and statistical manual of mental disorders
  9. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 2004, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome, Fertil Steril, 81, 19, 10.1016/j.fertnstert.2003.10.004 · DOI · Paper page
  10. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 2004, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS), Hum Reprod, 19, 41, 10.1093/humrep/deh098 · DOI · Paper page
  11. Papanicolaou, 1998, A single midnight serum cortisol measurement distinguishes Cushing’s syndrome from pseudo-Cushing states, J Clin Endocrinol Metab, 83, 1163
  12. Holm, 1979, A simple sequentially rejective multiple test procedure, Scand J Statist, 6, 65
  13. Barry, 1997, Test characteristics and decision rules, Endocrinol Metab Clin North Am, 26, 45, 10.1016/S0889-8529(05)70233-4 · DOI
  14. Glantz, 2005, Primer of biostatistics, 6th ed. New York: McGraw-Hill Professional;, 242
  15. Shultz, 1995, Multivariate receiver-operating characteristic curve analysis: prostate cancer screening as an example, Clin Chem, 41, 1248, 10.1093/clinchem/41.8.1248 · DOI
  16. Hosmer, 2000, Applied logistic regression, 2nd ed. New York: John Wiley and Sons;, 160
  17. DeLong, 1988, Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach, Biometrics, 44, 837, 10.2307/2531595 · DOI · Paper page
  18. Carpenter, 1988, Diagnostic evaluation of Cushing’s syndrome, Endocrinol Metab Clin North Am, 17, 445, 10.1016/S0889-8529(18)30412-2 · DOI
  19. Harris, 2002, Endocrinology in clinical practice, 10.1201/b15291 · DOI
  20. Erkut, 1998, Glucocorticoids suppress corticotropin-releasing hormone and vasopressin expression in human hypothalamic neurons, J Clin Endocrinol Metab, 83, 2066
  21. Itoi, 1987, Suppression by glucocorticoid of the immunoreactivity of corticotropin-releasing factor and vasopressin in the paraventricular nucleus of rat hypothalamus, Neurosci Lett, 73, 231, 10.1016/0304-3940(87)90250-3 · DOI
  22. McFarlane, 1995, Cortisol feedback in adrenalectomized adult sheep, Am J Physiol, 269, E10
  23. Shipston, 1991, Early glucocorticoid feedback in anterior pituitary corticotrophs: differential inhibition of hormone release induced by vasopressin and corticotrophin-releasing factor in vitro, J Endocrinol, 129, 261, 10.1677/joe.0.1290261 · DOI
  24. Nicholson, 1989, Glucocorticoids act rapidly in vitro to attenuate second messenger responses to ACTH secretagogues in rats, J Endocrinol, 122, 545, 10.1677/joe.0.1220545 · DOI
  25. Schwartz, 1994, Secretion of adrenocorticotrophin (ACTH) and ACTH precursors in ovine anterior pituitary cells: actions of corticotrophin-releasing hormone, arginine vasopressin and glucocorticoids, J Endocrinol, 140, 189, 10.1677/joe.0.1400189 · DOI
  26. Durand, 1986, In vitro stimulation and inhibition of adrenocorticotropin release by pituitary cells from ovine fetuses and lambs, Endocrinology, 118, 1387, 10.1210/endo-118-4-1387 · DOI
  27. Juruena, 2004, The hypothalamic pituitary adrenal axis, glucocorticoid receptor function and relevance to depression, Rev Bras Psiquiatr, 26, 189, 10.1590/S1516-44462004000300009 · DOI · Paper page
  28. Young, 2006, Disordered adrenocorticotropin secretion in women with major depression, J Clin Endocrinol Metab, 91, 1924, 10.1210/jc.2005-2397 · DOI · Paper page
  29. Pecori Giraldi, 2003, Corticotrophin-releasing activity of desmopressin in Cushing’s disease: lack of correlation between in vivo and in vitro responsiveness, J Endocrinol, 177, 373, 10.1677/joe.0.1770373 · DOI
  30. Zakowski, 2004, Evidence-based medicine: answering questions of diagnosis, Clin Med Res, 2, 63, 10.3121/cmr.2.1.63 · DOI

Cited by

See all 90

Metadata

Authors
Tirabassi, G., Faloia, E., Papa, R., Furlani, G., Boscaro, M., & Arnaldi, G.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2010-03-01
Volume
95
Issue
3
Pages
1115-1122
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2155233720
Cited by
90
References
10
FWCI
2.86
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Use of the Desmopressin Test in the Differential Diagnosis of Pseudo-Cushing State from Cushing’s Disease. https://app.cochat.ai/papers/10.1210/jc.2009-1146
The paper
Tirabassi, G., Faloia, E., Papa, R., Furlani, G., Boscaro, M., & Arnaldi, G. (2010). Use of the Desmopressin Test in the Differential Diagnosis of Pseudo-Cushing State from Cushing’s Disease. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2009-1146

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.